Product Name | MF | CAS | Details |
---|
Sitagliptin-d4 phosphate | C16H18F6N5O5P | 1432063-88-1 | Details |
(1-Cyclopropylcyclopropyl)methanamine hydrochloride | C7H14ClN | 1423027-90-0 | Details |
TOR1B antibody | Details |
3-(3,4-Dichlorophenyl)propan-1-ol | C9H10Cl2O | 39960-05-9 | Details |
Methyl bromoacetate | C3H5BrO2 | 96-32-2 | Details |
6-Cyano-1,2-dihydro-2-oxo-3-pyridinecarboxylic acid | C7H4N2O3 | 81450-71-7 | Details |
BNP-32, porcine | C149H250N52O44S3 | 117345-87-6 | Details |
4-Nitro-1-(2,2,2-trifluoroethyl)-1H-pyrazole | C5H4F3N3O2 | 919278-38-9 | Details |
Raucaffricine | C27H32N2O8 | 31282-07-2 | Details |
3-Amino-4-(4-methyl-1H-pyrazol-1-yl)benzamide | C11H12N4O | 1182766-09-1 | Details |
4-Methyl-N-[2-(propan-2-yl)phenyl]piperazine-1-carbothioamide | C15H23N3S | 1154914-67-6 | Details |
H-VVLSQGSK-OH | Details |
1-(4-methoxyphenyl)-4-(4-nitrophenyl)imidazole-2-thiol | C16H13N3O3S | 97814-14-7 | Details |
ZRANB2 antibody | Details |
2-(4-Nonylphenoxy)acetic acid | C17H26O3 | 3115-49-9 | Details |
[1-(But-3-yn-1-yl)-3-methylpiperidin-3-yl]methanol | 2154180-61-5 | Details |
1-[(5E)-5,6-Dideoxy-6-(diethoxy phosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil | C15H23N2O8P | 2095417-05-1 | Details |
3,9-Dibromo-5H,6H,8H,9H-[1,2,4]triazolo[4,3-d][1,4]oxazepine | C6H7Br2N3O | 2060053-25-8 | Details |
rac-(3R,4S)-4-Phenylpyrrolidin-3-ol, trans | C10H13NO | 1242166-68-2 | Details |
2-(Methylsulfanyl)thiophene-3-carboxylic acid | C6H6O2S2 | 71154-30-8 | Details |
1-(2-Methoxyethyl)-1-methylguanidine hydrochloride | C5H14ClN3O | 1423027-04-6 | Details |
N-(3-Amino-2-methylphenyl)butanamide | C11H16N2O | 946725-64-0 | Details |
(1-Cyanocycloheptyl)-carbamic acid tert-butyl ester | C13H22N2O2 | 904817-73-8 | Details |
3-(Trifluoromethyl)pyrazine-2-carbaldehyde | C6H3F3N2O | 1197238-20-2 | Details |
1,2,3,4-Tetrahydro-1,8-naphthyridin-4-ol | C8H10N2O | 1379218-50-4 | Details |
EG 00229 | C17H19N7O5S3 | 1018927-63-3 | Details |
3-Amino-4-sulfanylbenzonitrile | C7H6N2S | 802559-53-1 | Details |
5-Chloro-N-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | C19H18ClN3O5S | 865479-71-6 | Details |
8,8'-Bibaicalein | C30H18O10 | 135309-02-3 | Details |
H-Pro-Arg-bNA·HCl | C21H29ClN6O2 | 201998-83-6 | Details |
4-Chloro-1-(2,2-difluoroethyl)-1H-pyrazole-3-carboxylic acid | C6H5ClF2N2O2 | 1006486-42-5 | Details |
2-Azido-2-deoxy-3,4-O-isopropylidene-6-O-toluenesulfonyl-L-idonic acid methyl ester | Details |
(E)-Coniferol | C10H12O3 | 32811-40-8 | Details |
2-tert-Butyl 3-methyl 8-imino-8-oxo-8λ6-thia-2-azaspiro[4.5]decane-2,3-dicarboxylate | 2361645-12-5 | Details |
Methyl 4-chloro-1H-pyrrole-2-carboxylate | C6H6ClNO2 | 1194-96-3 | Details |
4-[(tert-Butylamino)methyl]phenol hydrochloride | C11H18ClNO | 1197950-06-3 | Details |
β-Glucanase 2, thermostable | 62213-14-3 | Details |
SLC35E2 antibody | Details |
2-Nitrophenyl-beta-D-glucopyranoside | C12H15NO8 | 2816-24-2 | Details |
2-[(4-Fluoro-2-methylphenyl)amino]acetonitrile | C9H9FN2 | 1021233-24-8 | Details |
Rhod-FRHDSGY-OH | Details |
Mecamylamine HCL | C11H22ClN | 826-39-1 | Details |
7-Chloro-8-methylquinoline-3-carboxylic acid | C11H8ClNO2 | 948290-52-6 | Details |
1-[(1,5-Dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-amine | C10H18N4O2S | 1018996-02-5 | Details |
(His(3-Me)2)-TRH trifluoroacetate salt | C17H24N6O4 | 34367-54-9 | Details |
HLI 373 dihydrochloride | C18H24ClN5O2 | 1782531-99-0 | Details |
3-(Dimethylamino)-2,2-difluoropropan-1-ol hydrochloride | C5H12ClF2NO | 2305252-90-6 | Details |
HMGCR Antibody Positive Human Plasma | Details |
Haptoglobin (Mixed Phenotypes), Highly Purified | Details |
Dimethicone - 90% | C6H18OSi2 | 9006-65-9 | Details |
2,5-Dimethyl-1-propyl-1H-pyrrole | C9H15N | 20282-39-7 | Details |
Ethyl[3-(pyrrolidin-1-yl)propyl]amine | C9H20N2 | 100708-28-9 | Details |
Rabdosiin | C36H30O16 | 263397-69-9 | Details |
1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)ethan-1-one | C13H14N2O | 1210-43-1 | Details |
6-Fluorobenzofuran-3-carboxylic acid | C9H5FO3 | 1393561-25-5 | Details |
(S)-(-)-3-Chloro-1-phenyl-1-propanol | C9H11ClO | 100306-34-1 | Details |
(3-Ethylazetidin-3-yl)methanol hydrochloride | C6H14ClNO | 1909310-02-6 | Details |
5-Iodo-2-nitrobenzoic acid | C7H4INO4 | 35674-28-3 | Details |
cis-4-Hydroxy-L-proline | C5H9NO3 | 618-27-9 | Details |
N-Isopropylcycloheptanamine | C10H21N | 52703-18-1 | Details |
4-(1-Methyl-1H-imidazol-2-yl)piperidine | C9H15N3 | 1084976-68-0 | Details |
2-(3,4-Dimethylcyclohex-3-en-1-yl)propan-2-ol | C11H20O | 115941-97-4 | Details |
N-(4-Amino-2-chlorophenyl)-5-ethylthiophene-2-carboxamide | C13H13ClN2OS | 1282572-28-4 | Details |
Ethyl 2-cyano-4,4-dimethoxybutanoate | C9H15NO4 | 773076-83-8 | Details |
LETM1 Blocking Peptide | Details |
3-Methyl-4-(3-methylpyrrolidin-1-yl)benzonitrile | C13H16N2 | 1247450-79-8 | Details |
N-(4-(((4-methylpyrimidin-2-yl)amino)sulfonyl)phenyl)(4-(trifluoromethyl)phenyl)formamide | C19H15F3N4O3S | 667887-29-8 | Details |
O-tert-Butyl-L-threonine tert-butyl ester | C12H25NO3 | 5854-78-4 | Details |
Protein Kinase C Substrate, Glycogen Synthase (1-8) | C56H104N18O15 | Details |
(2-Phenylcyclopentyl)methanamine | C12H17N | 1504990-93-5 | Details |
CUGBP2 antibody | Details |
GBM ELISA kit | Details |
UGT1A9 Blocking Peptide | Details |
5-[(2-Methoxyphenyl)(methyl)sulfamoyl]-2-methylbenzoic acid | C16H17NO5S | 380342-16-5 | Details |
4-Fluoro-3-(methanesulfonyl)phenylboronic acid | C7H8BFO4S | 1268496-35-0 | Details |
NCoA2 antibody | Details |
4-Chloro-2-(2,6-dimethylpiperidine-1-carbonyl)aniline | C14H19ClN2O | 953745-28-3 | Details |
TCTA Blocking Peptide | Details |
1,2-Diiodoethene | C2H2I2 | 590-27-2 | Details |
2-Bromo-2-cyclohexen-1-ol | C6H9BrO | 61426-49-1 | Details |
SSR 504734 hydrochloride | C20H20ClF3N2O.HCl | 615571-23-8 | Details |
Methyl 4-amino-2-methyl-1H-indole-1-carboxylate | C11H12N2O2 | 2219376-54-0 | Details |
4-(1,1,2-trimethyl-1h-benzo[e]indolium-3-yl)butane-1-sulfonate | C19H23NO3S | 63149-24-6 | Details |
N-(2-methoxy-5-methylphenyl)-2-(4-(2-pyridyl)piperazinyl)ethanamide | C19H24N4O2 | 303091-92-1 | Details |
rac-(1R,2R)-1-Bromo-2-methoxycyclohexane | C7H13BrO | 5927-93-5 | Details |
5-Methyl-L-norleucine | C7H15NO2 | 31872-98-7 | Details |
H-KSIHIGPGRAFYATG-OH | Details |
H-DYKDDDDKDYKDDDDKDYKDDDDK-OH | Details |
1-Phenyl-4-(propan-2-yl)-1H,6H,7H-pyrazolo[3,4-d]pyridazin-7-one | C14H14N4O | 1105196-52-8 | Details |
1-(1H-Indol-5-yl)-2-methoxyethan-1-amine | 1270451-31-4 | Details |
L-Homoserine | C4H9NO3 | 672-15-1 | Details |
Atriopeptin I (rat) | C83H135N29O30S2 | 89139-53-7 | Details |
2'-Deoxy-5'-O-DMT-N2-isobutyrylguanosine 3'-Rp-oxazaphospholidine | Details |
H-GDKA-OH | Details |
(2-Cyclopropylethyl)(cyclopropylmethyl)amine hydrochloride | C9H18ClN | 1989672-86-7 | Details |
Methyl (3S)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride | C11H14ClNO3 | 178205-92-0 | Details |
Quinolin-4-amine hydrochloride | C9H9ClN2 | 35654-61-6 | Details |
2-Aminobicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride | 2253632-91-4 | Details |
5-Bromo-N,N,4-trimethylpyrimidin-2-amine | C7H10BrN3 | 1368039-53-5 | Details |
Recombinant Mouse Fas Ligand | Details |
Product Total: Product Page: | ||||
15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |